Bar Berta Abelis - 18 Mar 2026 Form 3 Insider Report for CollPlant Biotechnologies Ltd (CLGN)

Reporting relationship: VP Legal
Issuer ticker: CLGN
Reported as of: 18 Mar 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 18 Mar 2026, 10:16:37 UTC
Next SEC filing: 08 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Bar Abelis

Key filing fact

Bar Berta Abelis filed Form 3 for CollPlant Biotechnologies Ltd (CLGN) on 18 Mar 2026.

Key facts

This page summarizes Bar Berta Abelis's Form 3 filing for CollPlant Biotechnologies Ltd (CLGN).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Mar 2026, 10:16.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002120230 Primary reporting owner

Abelis Bar Berta

Relationship: VP Legal
Address: C/O COLLPLANT BIOTECHNOLOGIES LTD., 4 OPPENHEIMER ST, WEIZMANN SCIENCE PARK, REHOVOT, ISRAEL
Signature: /s/ Bar Abelis
Signature date: 18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLGN holding

Restricted Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 13,000
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1, F2

CLGN holding

Restricted Share Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 40,000
Date: 18 Mar 2026
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLGN holding Derivative

Options to Purchase Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 18 Mar 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 20,000
Exercise price: $7.50
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee or director in connection with the Issuer's Share Ownership and Option Plan (2010) or 2024 Share Award Plan must be registered in the name of a trustee.

Footnote F2

Of the restricted share units reported herein, 5,686 units are vested, and the remaining 7,314 units vest in nine equal quarterly installments beginning June 8, 2026 and ending June 8, 2028, subject to the Reporting Person's continued service to the Issuer as of such vesting date.

Footnote F3

The restricted share units shall vest over a period of 3 years as follows: 33% shall vest on November 25, 2026, and the remaining 67% shall vest in eight equal quarterly installments thereafter.

Footnote F4

13,750 options are fully vested and exercisable. The remaining 6,250 options shall vest and become exercisable in five equal quarterly installments beginning March 28, 2026 and ending March 28, 2027, subject to the Reporting Person's continued service to the Issuer as of such vesting date.